BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24701595)

  • 1. Is (18)F-FDG PET really a promising marker for clinically relevant atherosclerosis?
    Brammen L; Palumbo B; Lupattelli G; Sinzinger H
    Hell J Nucl Med; 2014; 17(1):62-3. PubMed ID: 24701595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
    Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Iwaki T; Mizuma H; Hokamura K; Onoe H; Umemura K
    Biomed Res Int; 2016; 2016():8609274. PubMed ID: 28101514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should vascular wall
    Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET.
    Bural GG; Torigian DA; Basu S; Bozkurt MF; Houseni M; Alavi A
    Hell J Nucl Med; 2013; 16(3):164-8. PubMed ID: 24137578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
    Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
    J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
    Folco EJ; Sheikine Y; Rocha VZ; Christen T; Shvartz E; Sukhova GK; Di Carli MF; Libby P
    J Am Coll Cardiol; 2011 Aug; 58(6):603-14. PubMed ID: 21798423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by
    Li X; Heber D; Cal-Gonzalez J; Karanikas G; Mayerhoefer ME; Rasul S; Beitzke D; Zhang X; Agis H; Mitterhauser M; Wadsak W; Beyer T; Loewe C; Hacker M
    J Nucl Med; 2017 Jun; 58(6):968-974. PubMed ID: 28232606
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro.
    Ogawa M; Nakamura S; Saito Y; Kosugi M; Magata Y
    J Nucl Med; 2012 Jan; 53(1):55-8. PubMed ID: 22128324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET imaging of atherosclerosis: Do we know what we see?
    Sheikine Y; Akram K
    Atherosclerosis; 2010 Aug; 211(2):371-80. PubMed ID: 20202637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of
    Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
    Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.